Healthcare Investment Banking
Founded in 2000, VelocityHealth Securities operates a financial advisory firm and a middle market investment banking firm focused on growth companies within all healthcare sectors including: specialty pharmaceuticals, biotechnology, diagnostics, healthcare information technology (HCIT), healthcare services, medical devices, and generic pharmaceuticals.
VHS offers mergers and acquisitions advisory services for sponsors and companies with enterprise value transactions from $10 million to $500 million, including buy-sides, recapitalizations, sell-sides and fairness opinions. We also advise growth companies with seeking growth capital including equity, subordinated debt, and senior debt. Our typical equity client is seeking between $5 million to $100 million in growth capital.
Additionally, VHS offers advisory services for companies regarding business development and strategic relationships such as: in-licensing and out-licensing of products and technologies, channel partners, and corporate partnering.
VelocityHealth Securities, Inc.
95 White Bridge Road, Suite 409
Nashville, TN 37205 USA
Franco Merckling, PhD, accomplished biopharmaceutical executive with more than 20 years of successful commercial and General Management experience with leading pharmaceutical companies (Lilly, Merck and Eisai) and Biotech Start Up companies (Kenta, Immodulon). Successful planning and execution of major corporate development projects (Therametrics, Rentschler, Sanochemia), extensive experience in both start-up and change management. Franco holds a PhD degree in Chemistry from the University of Zurich.
Franco has successfully planned and implemented company startup ventures (Greenfield), company asset sale transactions, global restructuring projects, divisions’ spin-off projects (complete manufacturing site) as well as financing & capital increase transactions.